Latest Refining News

White Cliff Minerals has unveiled assay results from its 2025 drilling campaign at the Danvers prospect, significantly extending the known high-grade copper mineralisation and revealing new geophysical targets that promise further discoveries.

Wellnex Life Limited reported a robust 40.5% revenue increase in FY25, driven by the full-year integration of Pain Away, while margin recovery gains momentum in the second half.

Avada Group Limited has updated its FY25 financial results, reducing its loss after tax by $2.04 million due to tax benefit adjustments and reclassification of borrowings, while confirming no impact on operating revenue or cash flow.

Quantum Graphite Ltd reported a significant revenue jump alongside a $4.9 million net loss for FY2025, as it pushes forward with its Uley 2 graphite project backed by major infrastructure and funding initiatives.

ParagonCare has released its audited FY25 financial results, confirming steady profit while revealing a significant reclassification of debt and ongoing challenges with a major retail pharmacy receivable.

Paradigm Biopharmaceuticals has dosed participants in its pivotal Phase 3 trial for knee osteoarthritis across the US and Australia, progressing steadily towards a mid-2026 interim analysis.

Toubani Resources has reported promising drill results extending gold mineralisation beyond the current Kobada resource estimate, highlighting potential for resource growth both near surface and at depth.

Papyrus Australia has appointed Daniel Schmidt as CEO and secured a $250k government grant alongside a binding agreement to produce biodegradable mining products, marking a decisive shift from R&D to commercial operations.

Tungsten Mining NL has successfully raised $9.5 million through a share placement to advance its Mt Mulgine gold-tungsten project, reinforcing its position in the global tungsten market.

Power Minerals confirms a high-grade carbonatite hard rock intrusion at its Santa Anna Rare Earth Elements Project in Brazil, with promising grades and ongoing drilling aimed at defining a maiden resource estimate.

DeSoto Resources has identified promising new gold anomalous zones at its Tole and Dadjan projects in Guinea, with soil and rock chip assays confirming widespread mineralisation ahead of maiden drilling programs.

Syntara Limited has reported encouraging Phase 2a results for amsulostat combined with ruxolitinib in treating myelofibrosis, demonstrating sustained symptom improvement and spleen volume reduction over 52 weeks.